FOLFOXIRI in combination with panitumumab as first-line treatment in quadruple wild-type (KRAS, NRAS, HRAS, BRAF) metastatic colorectal cancer patients: a phase II trial by the Gruppo Oncologico Nord Ovest (GONO).

Fornaro L; Lonardi S; Masi G; Loupakis F; Bergamo F; Salvatore L; CREMOLINI, CHIARA; Schirripa M; Vivaldi C; Aprile G; Zaniboni A; Bracarda S; FONTANINI, GABRIELLA; Sensi E; Lupi C; Morvillo M; Zagonel V; FALCONE, ALFREDO

research article

oai:arpi.unipi.it:11568/429270

FOLFOXIRI in combination with panitumumab as first-line treatment in quadruple wild-type (KRAS, NRAS, HRAS, BRAF) metastatic colorectal cancer patients: a phase II trial by the Gruppo Oncologico Nord Ovest (GONO).

Authors: Fornaro L
Lonardi S
Masi G
Loupakis F
Bergamo F
Salvatore L
CHIARA CREMOLINI
Schirripa M
Vivaldi C
Aprile G
Zaniboni A
Bracarda S
GABRIELLA FONTANINI
Sensi E
Lupi C
Morvillo M
Zagonel V
ALFREDO FALCONE
Publication date: 1 January 2013
Publisher
Doi

Abstract

Abstract is not available.

info:eu-repo/semantics/article

Similar works

Full text

Archivio della Ricerca - Università di Pisa

oai:arpi.unipi.it:11568/429270

Last time updated on 13/04/2017

This paper was published in Archivio della Ricerca - Università di Pisa.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.